Chairman, Board of Advisors
Len Chaikind has an extensive background in oil and gas international relations, including working for Royal Dutch Shell Plc for over 35 years.
While with Shell, Chaikind worked in a wide variety of assignments.
He was appointed regional treasurer for Shell operations in the Far East and Australasia negotiating and financing over $50 billion of both corporate and major project activities.
Additionally, Chaikind developed many significant relationships with key government officials and financial institutions in, Brunei, China, Yemen, France, Switzerland, Nigeria and Saudi Arabia. He also served as an active member of the Commodity Futures Trading Commission Advisory Board.
Since leaving Shell, Chaikind has worked with tax-exempt funds, including healthcare, pension plans and social security reforms, and still maintains a strong presence in Washington, D.C.
Maggie Dodd White Eagle
Maggie Dodd White Eagle is a Managing Director of IICC (founded by Leonard Chaikind), the Owner of RTW Consulting, and serves on several advisory boards for national and international projects dealing with economic development, infrastructure rebuilding, education, and human rights issues.
Ms. Dodd White Eagle is a lifelong educator with a Master's of Indigenous Peoples law. She serves as the volunteer Native American community outreach director and member of the advisory committee for Independent Security Advisors. An Advisor to the Board for the Power District Educational and Cultural Charitable Foundation Inc. she is involved in rebuilding the infrastructure of Rockford Illinois. She also is the Regional Director for Malika Africa working with the Massai people of Tanzania on human rights, cultural protection, health, and education issues.
At the beginning of her career, Ms. Dodd White Eagle was involved with the NFL and was involved in observing brain research studies in regards to the players, concussions, and CTE. As an educator, Ms.Dodd White Eagle was also involved in brain research studies involving the acquisition of learning for educational program development.
As a daughter of a mother who suffered from a stroke, she used these experiences to retrain her mother's brain in stroke recovery. The research she did with her father looking for answers for her mother led her to learn about the research of Dr. Robert Spengler and Dr. Tracey Ignatowski. Her mother was never able to receive the benefits of the treatment based on the research as she passed away.
As a member of the Advisory Board for BBRI Ms. Dodd White Eagle brings her years of business and education development to the table in hopes of assisting Dr. Spengler and Dr. Ignatowski’s research to not only continue but to bring solutions for stroke, traumatic brain injury, and now long-range covid into the lives of families everywhere.
Ilia J Elenkov, MD, PhD
Edward Tobinick, M.D.
Edward Tobinick, M.D. is founder/Director of the Institute of Neurological Recovery in Boca Raton, Florida which practices perispinal delivery of etanercept, a method he invented. Dr. Tobinick presented scientific findings regarding perispinal etanercept at conferences including the Karolinska Institute Drug Repositioning Summit; International Conference on Alzheimer’s Disease; Alzheimer’s Drug Discovery Conference; International Restauracion Neurologica; World Pharmaceutical Congress and Modern Drug Discovery Conference. He has authored 30+ peer-reviewed scientific papers. His inventions have received 25+ patents.
Dr. Tobinick graduated Phi Beta Kappa and Magna Cum Laude from Brandeis University and received his M.D. from U.C. San Diego School of Medicine, completing post-graduate training in Internal Medicine at UCLA. He is board-certified by the American Board of Internal Medicine. He has been an expert reviewer for the journals Brain Research, Clinical Drug Investigation, CNS Drugs, Current Alzheimer Research, Drug Discovery Today, Experimental Neurology, Future Neurology, Journal of Neurochemistry, Journal of Neuroimmunology, Neuroscience, and Pharmaceutical Medicine and Editorial Board member of the Journal of Neuroinflammation.
George Schroeder, M.D.
George Schroeder, MD, MS, FACEP, FAAUCM, graduated as an MD from the University of Toronto, Faculty of Medicine, Toronto, Ontario, Canada and earned a Master of Science degree from University of Texas at Dallas Graduate School of Healthcare Management, Dallas Texas, USA. Following a 33-year career as a hospital-based clinical Emergency Physician, and 6 years as Director of Emergency Medical Services; he was appointed Medical Director of the North Florida Comprehensive Treatment Center, for Acadia Healthcare, Inc. treating patients for addiction.
Dr. Schroeder has served as Clinical Assistant Professor @ Southern Illinois University, Carbondale, Illinois as well as Clinical Assistant Professor of Emergency Medicine at the University of Central Florida College of Medicine, Orlando, Florida, USA; and was appointed by the Governor of Florida to the Pharmaceutical & Therapeutics Committee for the State of Florida. His Clinical Faculty appointments also include serving as Clinical Adjunct Professor for Liberty University College of Medicine & Lake Erie College of Medicine. Dr. Schroeder serves on the International Scientific Advisory Board of Magellan BioScience, Tampa , Florida. He is Editor in- chief of the Editorial Board of the Journal of Marine Sciences, Research & Development and Senior Medical Editor of the Journal of American Academy of Urgent Care Medicine as well as Medical Editor of the Journal of Freestanding Emergency Medicine. He is a CLIA-certified Laboratory Director, and he has served as Associate Medical Director for Octapharma Plasma, in Florida. In addition, he has worked as a senior medical consultant, subcontracted to Novartis Biopharmaceutical Co. Inc. in administering FDA approved pharmaceutical products initiating and monitoring treatment and clinical outcomes in patients with Multiple Sclerosis.
Dr. Schroeder also serves as Associate Editor for Marine Biotechnology in the Swiss global on-line publishing organization – Frontiers in Marine Science. Dr. Schroeder served as Founder, President & CEO of North American Renaissance Marine Project, N.A.R.M.P.R.O., LLC. as well as an Associate member of the American Academy of Underwater Sciences. He has published 37 peer reviewed articles in clinical journals , as well as in newsletters, on the potential of STEM Cell research, and Biosimilar Biopharmaceutical products, in his role as member of the Editorial Board of Policy & Medicine – a Rockville , Maryland consortium of Biomedical experts in Washington DC, as well as a book Chapter in the College Textbook : Blue Biotechnology – Production & Use of Marine Molecules , titled: Bioactive Marine Molecules and Derivatives with Biopharmaceutical Potential.
He continues to pursue his interests in a wide range of Biomedical Marine Sciences with an emphasis on Marine Toxins, Marine Biopharmaceuticals and aquatic hazards. He has served as Executive Director of the American Academy of Urgent Care Medicine in Orlando, Florida, USA and continues to serve on the Executive Council as the Chairman of the International Urgent Care Medicine Committee as well as continuing to serve on the Board of Directors of the American Board of Urgent Care Medicine.